We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.05B
Cap. Flow %
-17.25%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 24.85%
2 Technology 15.39%
3 Consumer Discretionary 13.45%
4 Industrials 10.48%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAIN icon
1151
Main Street Capital
MAIN
$5.48B
$351K ﹤0.01%
+9,210
New +$351K
TDC icon
1152
Teradata
TDC
$2.55B
$349K ﹤0.01%
8,696
-11,345
-57% -$457K
CVG
1153
DELISTED
Convergys
CVG
$347K ﹤0.01%
+14,194
New +$338K
TLP
1154
DELISTED
Transmontaigne
TLP
$346K ﹤0.01%
9,396
-12,676
-57% -$481K
COLL icon
1155
Collegium Pharmaceutical
COLL
$956M
$345K ﹤0.01%
+14,447
New +$355K
MCO icon
1156
Moody's
MCO
$82.7B
$345K ﹤0.01%
2,025
-17,358
-90% -$2.94M
ETN icon
1157
Eaton
ETN
$174B
$344K ﹤0.01%
4,600
-14,377
-76% -$1.11M
MAG
1158
DELISTED
MAG Silver
MAG
$343K ﹤0.01%
+31,649
New +$354K
HTLD icon
1159
Heartland Express
HTLD
$956M
$342K ﹤0.01%
+18,439
New +$341K
PGRE
1160
DELISTED
Paramount Group
PGRE
$331K ﹤0.01%
+21,493
New +$317K
CPRX
1161
DELISTED
Catalyst Pharmaceutical
CPRX
$329K ﹤0.01%
+105,345
New +$320K
OSG
1162
DELISTED
Overseas Shipholding Group Inc.
OSG
$329K ﹤0.01%
+84,719
New +$305K
ARE icon
1163
Alexandria Real Estate Equities
ARE
$8.56B
$328K ﹤0.01%
+2,600
New +$325K
DHC
1164
Diversified Healthcare Trust
DHC
$2.14B
$328K ﹤0.01%
+18,133
New +$300K
AFL icon
1165
Aflac
AFL
$62.6B
$327K ﹤0.01%
7,600
-376,883
-98% -$16.9M
PBH icon
1166
Prestige Consumer Healthcare
PBH
$2.6B
$327K ﹤0.01%
+8,535
New +$288K
RM icon
1167
Regional Management Corp
RM
$303M
$326K ﹤0.01%
+9,308
New +$325K
BHC icon
1168
Bausch Health
BHC
$2.34B
$323K ﹤0.01%
+13,900
New +$287K
WMC
1169
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$322K ﹤0.01%
+3,087
New +$316K
HLX icon
1170
Helix Energy Solutions
HLX
$1.41B
$320K ﹤0.01%
38,417
-70,017
-65% -$514K
BAP icon
1171
Credicorp
BAP
$30.7B
$318K ﹤0.01%
1,411
-67,288
-98% -$15.3M
AXTA icon
1172
Axalta
AXTA
$8.17B
$317K ﹤0.01%
10,445
+3,282
+46% +$103K
STG
1173
Sunlands Technology
STG
$45.5M
$316K ﹤0.01%
+2,838
New +$323K
SBBP
1174
DELISTED
Strongbridge Biopharma plc.
SBBP
$315K ﹤0.01%
+52,546
New +$384K
LYG icon
1175
Lloyds Banking Group
LYG
$91.3B
$314K ﹤0.01%
94,379
-13,044
-12% -$46.4K
45 46
47
48 49

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.